FIELD: medicine.
SUBSTANCE: claimed is application of known anticonvulsant lamotrigine (other names of substance - lamictal, lamolep) as medication, which prevents ischemic and hypoxic disorders in acute period of craniocerebral injury. Demonstrated is prevention of secondary disorders of brain functions as a result of ischemia, hypoxia with hypercapnia, hemic hypoxia with simultaneous facilitation of recovering neuro-physical status.
EFFECT: lamotrigine increases brain stability to major factors of its secondary injury by 24,9-42,6% and improves life duration of mice in post traumatic period by 109,6%.
5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT SHOWING MULTIFACTOR NEUROPROTECTIVE AND NOOTROPIC EFFECT IN CRANIAL TRAUMA | 2005 |
|
RU2318501C2 |
| MEDICATION PRODUCING ANTI-ISCHEMIC, ANTIHYPOXIC AND ANTIAMNESTIC ACTION IN ACUTE PERIODE OF CRANIOCEREBRAL TRAUMA | 2009 |
|
RU2424802C2 |
| MEDICINAL AGENT OFFERING ANTI-ISCHEMIC, ANTIHYPOXIC AND ANTICONVULSANT EFFECT IN CRANIAL TRAUMA | 2005 |
|
RU2309745C2 |
| ANTICONVULSANT AND ANTIHYPOXIC AGENT | 2008 |
|
RU2393857C2 |
| METHOD OF TREATING CRANIOCEREBRAL INJURY AND AGENT FOR IMPLEMENTATION THEREOF | 2023 |
|
RU2826364C1 |
| METHOD FOR TREATMENT OF CEREBROVASCULAR BRAIN DISORDERS (OPTIONS) | 2017 |
|
RU2659674C1 |
| REMEDY FOR PREVENTING EDEMA | 1988 |
|
RU2049464C1 |
| IN VIVO METHOD FOR DETERMINING BIOCOMPATIBILITY OF SCAFFOLDS FOR NEUROTRANSPLANTATION | 2021 |
|
RU2812608C2 |
| MEDICINAL AGENT WITH ANTIHYPOXIC, ANTISTROKE, MEMORY-REFINING ACTION | 2007 |
|
RU2326665C1 |
| NEUROTROPIC AGENT WITH ANTIOXIDANT, ANTIHYPOXIC, NEUROPROTECTOR, ANTIAMNESIC AND ANTI-MOTION SICKNESS ACTIVITY AND CAPABLE OF ENHANCING COGNITIVE FUNCTIONS | 2008 |
|
RU2394816C1 |
